Tristel (TSTL) Competitors GBX 417 +4.50 (+1.09%) As of 07/11/2025 12:29 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsDividendEarningsHeadlinesInsider TradesBuy This Stock TSTL vs. AMS, BVC, SPEC, AKR, CNSL, ODX, CTEC, ERGO, CSRT, and SLNShould you be buying Tristel stock or one of its competitors? The main competitors of Tristel include Advanced Medical Solutions Group (AMS), BATM Advanced Communications (BVC), INSPECS Group (SPEC), Akers Biosciences (AKR), Cambridge Nutritional Sciences (CNSL), Omega Diagnostics Group (ODX), ConvaTec Group (CTEC), Ergomed (ERGO), Consort Medical plc (CSRT.L) (CSRT), and Silence Therapeutics (SLN). These companies are all part of the "medical" sector. Tristel vs. Its Competitors Advanced Medical Solutions Group BATM Advanced Communications INSPECS Group Akers Biosciences Cambridge Nutritional Sciences Omega Diagnostics Group ConvaTec Group Ergomed Consort Medical plc (CSRT.L) Silence Therapeutics Tristel (LON:TSTL) and Advanced Medical Solutions Group (LON:AMS) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their media sentiment, valuation, dividends, profitability, risk, earnings, analyst recommendations and institutional ownership. Does the media refer more to TSTL or AMS? In the previous week, Tristel had 1 more articles in the media than Advanced Medical Solutions Group. MarketBeat recorded 1 mentions for Tristel and 0 mentions for Advanced Medical Solutions Group. Advanced Medical Solutions Group's average media sentiment score of 1.43 beat Tristel's score of 1.16 indicating that Advanced Medical Solutions Group is being referred to more favorably in the news media. Company Overall Sentiment Tristel Positive Advanced Medical Solutions Group Positive Do analysts recommend TSTL or AMS? Advanced Medical Solutions Group has a consensus price target of GBX 300, suggesting a potential upside of 46.70%. Given Advanced Medical Solutions Group's stronger consensus rating and higher possible upside, analysts plainly believe Advanced Medical Solutions Group is more favorable than Tristel.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Tristel 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Advanced Medical Solutions Group 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is TSTL or AMS a better dividend stock? Tristel pays an annual dividend of GBX 13 per share and has a dividend yield of 3.1%. Advanced Medical Solutions Group pays an annual dividend of GBX 2 per share and has a dividend yield of 1.0%. Tristel pays out 95.1% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Advanced Medical Solutions Group pays out 38.8% of its earnings in the form of a dividend. Is TSTL or AMS more profitable? Tristel has a net margin of 15.47% compared to Advanced Medical Solutions Group's net margin of 8.49%. Tristel's return on equity of 20.43% beat Advanced Medical Solutions Group's return on equity.Company Net Margins Return on Equity Return on Assets Tristel15.47% 20.43% 9.89% Advanced Medical Solutions Group 8.49%4.57%2.35% Which has stronger valuation and earnings, TSTL or AMS? Advanced Medical Solutions Group has higher revenue and earnings than Tristel. Tristel is trading at a lower price-to-earnings ratio than Advanced Medical Solutions Group, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTristel£42.24M4.72£6.54M£13.6630.52Advanced Medical Solutions Group£132.18M3.34£11.22M£5.1639.63 Do institutionals & insiders hold more shares of TSTL or AMS? 50.4% of Tristel shares are held by institutional investors. Comparatively, 58.2% of Advanced Medical Solutions Group shares are held by institutional investors. 4.9% of Tristel shares are held by insiders. Comparatively, 3.1% of Advanced Medical Solutions Group shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. Which has more volatility and risk, TSTL or AMS? Tristel has a beta of 0.23, indicating that its share price is 77% less volatile than the S&P 500. Comparatively, Advanced Medical Solutions Group has a beta of 0.74, indicating that its share price is 26% less volatile than the S&P 500. SummaryAdvanced Medical Solutions Group beats Tristel on 10 of the 18 factors compared between the two stocks. Get Tristel News Delivered to You Automatically Sign up to receive the latest news and ratings for TSTL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding TSTL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TSTL vs. The Competition Export to ExcelMetricTristelMedical Instruments & Supplies IndustryMedical SectorLON ExchangeMarket Cap£199.20M£3.48B£5.62B£3.00BDividend Yield3.86%1.99%5.24%5.02%P/E Ratio30.5218.9928.10150.83Price / Sales4.72423.70429.70314,599.98Price / Cash20.96146.5437.4627.97Price / Book6.102.758.044.58Net Income£6.54M£99.80M£3.18B£5.90B7 Day Performance0.24%0.91%3.62%11.51%1 Month Performance8.37%-0.11%4.05%7.92%1 Year Performance-7.33%123.48%30.00%32.01% Tristel Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TSTLTristelN/AGBX 417+1.1%N/A-8.8%£199.20M£42.24M30.52208Positive NewsAMSAdvanced Medical Solutions Group2.758 of 5 starsGBX 203-1.7%GBX 300+47.8%-11.3%£438.33M£132.18M39.3410Positive NewsBVCBATM Advanced CommunicationsN/AGBX 15.50-2.2%N/A-24.2%£82.31M£130.32M-359.84980Positive NewsGap DownSPECINSPECS GroupN/AGBX 49.90+0.8%N/A-15.1%£50.73M£195.14M-12.351,673AKRAkers BiosciencesN/AN/AN/AN/A£21.64M£2.32M-0.44120CNSLCambridge Nutritional SciencesN/AGBX 4+3.9%N/A+6.5%£9.52M£9.77M-362.103,200Gap DownODXOmega Diagnostics GroupN/AN/AN/AN/A£5.23M£7.55M-220.0091Gap DownCTECConvaTec Group2.0894 of 5 starsGBX 259.60-1.4%GBX 305+17.5%+6.2%£6.60B£2.71B43.7210,000News CoverageAnalyst ForecastERGOErgomedN/AN/AN/AN/A£701.00M£152.09M4,641.386CSRTConsort Medical plc (CSRT.L)N/AN/AN/AN/A£504.60M£298.60M127.85N/ASLNSilence TherapeuticsN/AN/AN/AN/A£480.35M£11.35M-11.01100High Trading Volume Related Companies and Tools Related Companies Advanced Medical Solutions Group Competitors BATM Advanced Communications Competitors INSPECS Group Competitors Akers Biosciences Competitors Cambridge Nutritional Sciences Competitors Omega Diagnostics Group Competitors ConvaTec Group Competitors Ergomed Competitors Consort Medical plc (CSRT.L) Competitors Silence Therapeutics Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:TSTL) was last updated on 7/12/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his ...Porter & Company | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBank of America Says Gold Could Hit $4,000. Here How to Get PaidBank of America believes gold could hit $4,000 an ounce in the next 12 months. That's an 18% jump from toda...Investors Alley | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tristel plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Tristel With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
